Skin Basal Cell Carcinoma — Trials

Skin Basal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

83 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 11
Ph III recruiting: 2
Growth YoY: —
Industry share: 29%
Top sponsor: University of Rochester
Termination share: 10%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06398418	R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors	recruiting	Phase 1	33	Rise Therapeutics LLCINDUSTRY	1	Sep 18, 2026	clinicaltrials
NCT05859074	A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer	recruiting	Phase 1	56	Memorial Sloan Kettering Cancer CenterOTHER	1	Aug 12, 2026	clinicaltrials